STOCK TITAN

Sale of 24,001 ALLO shares (ALLO) planned under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of ALLO common stock has filed a Rule 144 notice to sell 24,001 shares through Morgan Stanley Smith Barney LLC on or about 02/02/2026 on NASDAQ. The aggregate market value of the planned sale is listed as $42,188.96, with issuer shares outstanding of 224,730,144.

The shares were acquired as restricted stock vesting under a registered compensation plan from the issuer on 01/31/2026, in a non-cash transaction classified as compensation. The seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Rule 144 filing disclose for ALLO?

The filing discloses a planned sale of 24,001 ALLO common shares under Rule 144, with an aggregate market value of $42,188.96, to be sold on NASDAQ around 02/02/2026 through Morgan Stanley Smith Barney LLC.

How many ALLO shares are planned to be sold and at what value?

The holder plans to sell 24,001 common shares of ALLO. The filing lists an aggregate market value of $42,188.96 for these shares, giving investors a sense of the transaction’s disclosed dollar size at the time of the notice.

How were the ALLO shares being sold under Rule 144 acquired?

The shares were acquired as restricted stock vesting on 01/31/2026 under a registered compensation plan from the issuer. The consideration is described as compensation, indicating the shares were granted rather than purchased for cash.

What does the filer represent about ALLO’s non-public information?

The person for whose account the securities will be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with the certification language included in the notice.

How many ALLO shares are reported as outstanding in the filing?

The notice reports 224,730,144 shares of the issuer’s common stock as outstanding. This figure provides context for the size of the planned 24,001-share sale relative to the issuer’s total reported common shares.

Which broker will handle the planned ALLO share sale under Rule 144?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker that will handle the planned sale of the 24,001 ALLO common shares on NASDAQ.
Allogene Therapeutics

NASDAQ:ALLO

ALLO Rankings

ALLO Latest News

ALLO Latest SEC Filings

ALLO Stock Data

404.51M
158.71M
17.45%
74.09%
8.99%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO